Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.
Exposure to Rituximab Biosimilars did not Increase Hypersensitivity Reaction Hospitalizations
March 14th 2023A recent study found no association between exposure to rituximab biosimilars and hospitalization for hypersensitivity reactions compared to the biologic at initiation, at switch, or over time.
Read More
Etanercept Biosimilars Outperform Biologic in ACR50 Response Rate at 1 Year
March 9th 2023Although etanercept biosimilars demonstrated comparable efficacy, safety, and immunogenicity when compared with the reference drug, biosimilar treatment was associated with a better ACR50 response rate.
Read More
Temporary Increase in Venous Thromboembolism Observed After Gout Flare
March 3rd 2023A brief increase in venous thromboembolism (VTE) was reported within 30 days after a hospitalization or primary care visit for gout flare. The highest incidence occurred during the 16-30 day period after the flare.
Read More
Physiotherapy, Qi Gong Improves Range of Motion, Muscle Strength in Patients With Fibromyalgia
March 2nd 2023Compared with the control group, patients in the exercise for wellbeing (Qi Gong) and physiotherapy groups reported statistically significant improvements at week 5 in joint range of movement, muscle strength, spirometry, and quality of life.
Read More
FDA Approves Sarilumab as First, Only Biologic Treatment for Polymyalgia Rheumatica
March 1st 2023The approval was based on positive results from the Phase 3 SAPHYR trial, which showed that nearly 3 times more patients achieved sustained remission with sarilumab when compared with placebo.
Read More
Better Self-Efficacy Linked to Better Health-Related Quality of Life in Patients With SLE
February 27th 2023Multivariable models indicated that improvements in the physical component score and mental component score could be predicted by better self-efficacy scores in patients with systemic lupus erythematosus.
Read More
Serological Screening Recommended for Patients With JIA and a Family History of Thyroid Disease
February 27th 2023Patients with juvenile idiopathic arthritis were at a greater risk of developing autoimmune thyroid disease if they were female, reported ANA and/or RF positivity, and a family history of thyroid disease.
Read More
Tocilizumab Biosimilar, MSB11456, Demonstrates Similar Pharmacokinetics, Safety Profiles
February 24th 2023A recent study found that the biosimilar MSB11456 showed pharmacokinetic similarity, immunogenicity, and safety profiles comparable to the reference drug, tocilizumab, suggesting that it could be a cost-effective alternative for treating autoimmune disorders.
Read More
Philip Mease, MD: Fibromyalgia Symptoms Improve When Underlying Condition is Treated
February 21st 2023Results of a recent study indicated that when a patient is able to temper their underlying disease, it can improve their experience of centrally sensitized pain despite not obtaining low disease activity.
Read More